MLC is building its development strategy based on our in-house developed technologies, which provide us with a competitive edge and allow us to independently enter the CGM market dominated by monopolists.
Why is it important?
Complex technologies are only available to a small number of companies, which makes the market for CGM systems undersaturated despite the growing demand.
We aim to become full-fledged participants alongside the industry giants and take our place in the CGM market. Our developed and patented technologies shaping intellectual property not only consolidate the company's capitalization, but also allow us to confidently advance towards opening a contract manufacturing line in China.
Now you have a chance to become a co-owner of the future production facility on favorable conditions! Hurry up, because as early as tomorrow, March 11, the discount on production shares will go down, their price will go up, and the number of them in the package will be reduced!
Check out the investment offerings in the price list: https://docs.google.com/spreadsheets/d/1JpsxnOP2JkV4RA-svi7OgIHQdEa-Vq-uHZFFevU8ZFc/edit?gid=0#gid=0
Manufacturing company presentation: https://mail-cdn.mlc.health/pdf/Establishment_of_a_manufacturing_company_in_CHINA_in_2025_EN.pdf
Don't put off your decision and take a step towards a successful future with MLC now!
